Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...

A new RAND report shows nearly 12% of U.S. adults now use GLP-1 drugs like Ozempic and Wegovy, and it’s changing how they shop. Food companies say the biggest shift isn’t in portion sizes but in the ...

Some of the most significant changes include what GLP-1 users eat at restaurants. Technomic data shows that one-third of ...

Today, the compounded GLP-1 market is in upheaval. The FDA has banned copies of GLP-1 weight loss drugs, and a number of ...

The impact of popular U. S. weight-loss drugs like Ozempic and Wegovy (GLP-1 receptor agonists), upon their initial ...

As California ends Medicaid coverage for GLP-1 weight loss drugs like Wegovy and Zepbound, experts say the state's advice to ...

WASHINGTON — US News & World Report named expansion of GLP-1 medications as the top health and nutrition trend for 2026.

Independent Analysis Examines ColonBroom GLP-1 Booster Ingredient Transparency, Non-Prescription Supplement Category Context, ...

GLP-1 weight-loss drugs have already seen massive success in the US. While they've made some headway into the European market ...

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to sustain once treatment ends. Stopping treatment with weight loss medications is ...

Direct Meds Reviews Prescription Access Pathways As New GLP-1 Formats Expand. LegitScript-certified telehealth platform ...